Rexin-G<sup>®</sup>, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report.

导出 LinkOut

翻译打印收藏纠错

作者： Seth,Kim ^[1] ; Noah,Federman ^[2] ; Erlinda M,Gordon ^[1] ; Frederick L,Hall ^[3] ; Sant P,Chawla ^[3]

作者单位： Sarcoma Oncology Center/Cancer Center of Southern California, Santa Monica, CA 90403, USA. ^[1] Department of Pediatrics, Division of Pediatric Hematology/Oncology, Mattel Children's Hospital at UCLA, Los Angeles, CA 90095, USA. ^[2] Counterpoint Biomedica LLC, Santa Monica, CA 90403, USA. ^[3]

关键词 cell cycle control metastatic sarcoma targeted gene therapy vector

DOI 10.3892/mco.2017.1231

PMID 28588778

发布时间 2020-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览21

Molecular and clinical oncology

2017年6卷6期

861-865页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Rexin-G<sup>®</sup>, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rexin-G<sup>®</sup>, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除